In AML, Immunotherapy Shows Promise to Expand Treatment Toolbox
Most of the research suggests combination therapies might be the best option for many patients who have acute myeloid leukemia (AML).
Source: ajmc.com
Stay updated with breaking news from Immune Microenvironment . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most of the research suggests combination therapies might be the best option for many patients who have acute myeloid leukemia (AML).